Han Kun advised Legend Capital Co., Ltd. in its investment in series C equity financing of Beijing Shenogen Pharma Group Ltd.
2014-01-13
Han Kun recently advised Legend Capital Co., Ltd. in its investment in series C equity financing of Beijing Shenogen Pharma Group Ltd. Han Kun team has fully involved in the investment, including conducting legal due diligence on the target company, carrying on negotiations and preparing a full set of financing documents. The leading investors in this transaction are Legend Capital and Qiming.
Yijun Chao, Evan Zhang, Ching King and Lu Ran worked on this transaction.